Conference - Institut Pasteur, Paris, France
Tuberculosis remains an enormous burden to human health even at the beginning of the 21st century. The situation is worsening in many countries, particularly due to the synergy with the HIV epidemic and the appearance of multi-drug resistant (MDR) or extensively-drug resistant (XDR) tuberculosis. The urgently needed development of new tools that can improve the diagnosis, prevention and/or therapy of tuberculosis and other major mycobacterial diseases depends largely on the progress made by basic and applied research.
The EMBO conference series "Tuberculosis 2012" is an international congress that provides a premium forum for the discussion and exchange of the recent advances of current research and novel trends related to tuberculosis, its causative agent Mycobacterium Tuberculosis and related pathogenic Mycobacteria. This international meeting to be held from September 11-15, 2012, will take place in the Conference centre (CIS) within the campus of the Institut Pasteur, which can host up to 500 conference delegates and is situated in the center of Paris, France.
The conference will be of interest to researchers, doctors, and representatives from industry with the focus on the biology of pathogenic mycobacteria and their interaction with their hosts.
(Courtesy of http://www.pasteur.fr/infosci/conf/sb/tuberculosis2012/)
Tue, Sep 11, 2012 - Sat, Sep 15, 2012
Institut Pasteur, Paris, France
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
